IL6 and cancer: For example, development of chronic inflammation via signalling molecules such as IL‐1A, IL‐6, IL‐8, CCL2 and CXCL is common in cancer patients, and consequences of systemic chemotherapy delivery are similar to those seen in ageing populations, such as frailty and insulin resistance [25].